Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 19.42
+0.36 (1.89%)
At close: Mar 6, 2026
Hualan Biological Vaccine Market Cap
Hualan Biological Vaccine has a market cap or net worth of 11.55 billion as of March 6, 2026. Its market cap has increased by 6.76% in one year.
Market Cap
11.55B
Enterprise Value
8.48B
Revenue
976.44M
Ranking
n/a
PE Ratio
163.99
Stock Price
19.42
Market Cap Chart
Since February 18, 2022, Hualan Biological Vaccine's market cap has decreased from 28.12B to 11.55B, a decrease of -58.91%. That is a compound annual growth rate of -19.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 11.55B | 4.24% |
| Dec 31, 2025 | 11.08B | 6.40% |
| Dec 31, 2024 | 10.42B | -37.54% |
| Dec 29, 2023 | 16.68B | -6.46% |
| Dec 30, 2022 | 17.83B | -36.59% |
| Feb 18, 2022 | 28.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 12.61B |
| Mabwell (Shanghai) Bioscience | 12.53B |
| Chengdu Olymvax Biopharmaceuticals | 11.88B |
| Staidson (Beijing) BioPharmaceuticals | 11.66B |
| InventisBio | 11.55B |
| Beijing Hotgen Biotech | 11.28B |
| HitGen | 10.60B |
| Chengzhi | 10.52B |